AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2017
Jun 8, 2017
31802_dirs_2017-06-08_5b89d9bf-da33-41db-a3fb-a82489ad65f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-06-07
Reporting Person: Lanning Mark R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-07 | Common Stock | M | 10000 | $9.50 | Acquired | 89005 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-07 | Stock Option (right to buy) | $9.50 | M | 10000 | Disposed | 2017-06-20 | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1800 | Indirect |
Footnotes
F1: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F2: These options were granted on June 20, 2007 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3